The global cardiometabolic disease market, valued at USD 34.1 billion in 2023, is projected to grow significantly due to rising cases of obesity, diabetes, and cardiovascular diseases. A combination of an aging population, sedentary lifestyles, and associated risk factors propels this growth, with the market expected to reach USD 54.8 billion by 2032, growing at […]
